IAIM
IONS icon

International Assets Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

International Assets Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.6K Buy
1,232
+11
+0.9% +$828 0.01% 1104
2026
Q1 		$91.7K Buy
1,221
+4
+0.3% +$316 0.01% 1039
2025
Q4 		$96.3K Sell
1,217
-6,990
-85% -$526K 0.01% 1022
2025
Q3 		$328K Hold
8,207
– – 0.03% 577
2025
Q2 		$324K Hold
8,207
– – 0.03% 585
2025
Q1 		$248K Hold
8,207
– – 0.02% 627
2024
Q4 		$285K Sell
8,207
-320,565
-98% -$12M 0.02% 597
2024
Q3 		$8.21K Buy
328,772
+319,065
+3,287% +$14.8M 0.02% 464
2024
Q2 		$463K Buy
9,707
+2,100
+28% +$86.1K 0.04% 389
2024
Q1 		$334K Buy
+7,607
New +$363K 0.03% 496
2021
Q2 		– Sell
-462
Closed -$26K – 1155
2021
Q1 		$26K Hold
462
– – ﹤0.01% 1199
2020
Q4 		$26K Buy
+462
New +$23K ﹤0.01% 1071

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
WMA
West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return

International Assets Investment Management's IONS Position: Q2 2026 in Review

International Assets Investment Management increased its Ionis Pharmaceuticals (IONS) stake by 0.9% in Q2 2026, buying an estimated $828 and bringing the position to 1,232 shares worth $97.6K. The position accounts for 0.01% of the portfolio, ranked #1104.

International Assets Investment Management first reported a position in IONS in Q4 2020 and has held it in 12 quarters since. The position peaked at $463K in Q2 2024. 110 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • International Assets Investment Management held 1,232 shares of Ionis Pharmaceuticals worth $97.6K as of Q2 2026.
  • International Assets Investment Management bought 11 Ionis Pharmaceuticals shares in Q2 2026, an estimated $828.
  • Ionis Pharmaceuticals made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1104 holding.
  • International Assets Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
  • International Assets Investment Management's Ionis Pharmaceuticals position peaked at $463K in Q2 2024.
  • 110 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.